Thrivent Financial For Lutherans Cytokinetics Inc Transaction History
Thrivent Financial For Lutherans
- $51.6 Billion
- Q4 2024
A detailed history of Thrivent Financial For Lutherans transactions in Cytokinetics Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 27,768 shares of CYTK stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,768
Previous 27,642
0.46%
Holding current value
$1.22 Million
Previous $1.46 Million
10.55%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$644 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$523 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$472 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$346 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$271 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.13B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...